KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to -$41.9 million.

  • National Health Investors' Cash from Financing Activities rose 930.01% to -$41.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.8 million, marking a year-over-year increase of 14606.61%. This contributed to the annual value of -$13.6 million for FY2024, which is 9200.56% up from last year.
  • As of Q3 2025, National Health Investors' Cash from Financing Activities stood at -$41.9 million, which was up 930.01% from -$129.5 million recorded in Q2 2025.
  • National Health Investors' 5-year Cash from Financing Activities high stood at $139.8 million for Q1 2025, and its period low was -$244.9 million during Q2 2022.
  • Its 5-year average for Cash from Financing Activities is -$53.6 million, with a median of -$43.8 million in 2024.
  • As far as peak fluctuations go, National Health Investors' Cash from Financing Activities crashed by 57170.04% in 2023, and later skyrocketed by 48908.19% in 2025.
  • National Health Investors' Cash from Financing Activities (Quarter) stood at -$86.0 million in 2021, then skyrocketed by 91.44% to -$7.4 million in 2022, then crashed by 571.7% to -$49.4 million in 2023, then surged by 327.37% to $112.4 million in 2024, then crashed by 137.29% to -$41.9 million in 2025.
  • Its Cash from Financing Activities was -$41.9 million in Q3 2025, compared to -$129.5 million in Q2 2025 and $139.8 million in Q1 2025.